Summary
Liver blood flow and indices of hepatic drug metabolism (antipyrine elimination rate and cytochrome P-450 concentration in liver biopsy specimens) were studied in 19 epileptics on long-term anticonvulsant treatment, and in 18 controls. The size of the liver and the total estimated liver blood flow were greater in the epileptics than in the controls, whereas the relative liver blood flow (per unit weight of the liver) was not significantly different. The epileptics had higher cytochrome P-450 levels and they eliminated antipyrine faster than the controls. It was concluded that long-term ingestion of enzyme-inducing anticonvulsants is associated with an increase in the total hepatic blood flow in parallel with the increase in liver size, and not as an independent phenomenon. Since the relative perfusion rate of the hepatocytes was unchanged, the enhanced activity of drug metabolizing enzymes is presumed to be mainly responsible for the increased drug clearance observed in epileptic subjects.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Conney AH (1967) Pharmacological implications of microsomal enzyme induction. Pharmacol Rev 19: 317–366
Schulte-Hermann R (1974) Induction of liver growth by xenobiotic compounds and other stimuli. CRC Crit Rev Toxicol 3: 97–158
Ohnhaus EE, Thorgeirsson SS, Davies DS, Breckenridge A (1971) Changes in liver blood flow during enzyme induction. Biochem Pharmacol 20: 2561–2570
Ohnhaus EE, Locher JT (1975) Liver blood flow and blood volume following chronic phenobarbitone administration. Eur J Pharmacol 31: 161–165
Ohnhaus EE, Tilvis R (1976) Liver blood flow, metabolic heat production and body temperature before, during and after phenobarbitone administration. Acta Hepato-Gastroenterol 23: 404–408
Branch RA, Shand DG, Wilkinson GR, Niess AS (1974) Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased liver blood flow. J Clin Invest 53: 1101–1107
Wilkinson GR, Shand DG (1975) A physiological approach to hepatic drug clearance. Clin Pharmacol Ther 18: 377–390
Pirttiaho HI, Pitkänen U (1977) Size and blood flow of the liver estimated by 99Tcm scanning. Acta Radiol (Ther Phys Biol) 16: 497–506
Dobson EL, Jones HB (1952) The behaviour of intravenously injected particulate material; its disappearance from blood stream as a measure of liver blood flow. Acta Med Scand 144: (Suppl) 273
Torrance HB (1966) The application of an external scintillation counter technique to investigate various aspects of splanchnic circulation in man. Rev Int Hepatol 16: 1011–1016
Rollo FD, DeLand F (1968) The determination of liver mass from radionuclide images. Radiology 91: 1191–1198
Greim H, Schenkman JB, Klotzbücher M, Remmer H (1970) The influence of phenobarbital on the turnover of hepatic microsomal cytochrome b5 and cytochrome P-450 hemes in the rat. Biochim Biophys Acta 201: 20–25
Prescott LL, Adjepon-Yamoah KK, Roberts E (1973) Rapid gas-liquid chromatographic estimation of antipyrine in plasma. J Pharm Pharmacol 25: 205–207
Total blood volume — its measurement and significance. Medical Monograph 3. The Radiochemical Centre, Amersham, England 1967
McDewit DG, Nies AS, Wilkinson GR (1977) Influence of phenobarbital on factors responsible for hepatic clearance of indocyanine green in the rat: relative contributions of induction and altered blood flow. Biochem Pharmacol 26: 1247–1250
Caesar J, Shaldon S, Chiandussi L, Guevara L, Sherlock S (1961) The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function. Clin Sci 21: 43–57
Melikian V, Eddy JD, Paton A (1972) The stimulant effect of drugs on indocyanine green clearance by the liver. Gut 13: 755–758
Roberts CJC, Jackson L, Halliwell M, Branch RA (1976) The relationship between liver volume, antipyrine clearance and indocyanine green clearance before and after phenobarbitone administration in man. Br J Clin Pharmacol 3: 907–913
Ohnhaus EE, Coninx S, Ramos MR, Noelp U (1976) Liver blood flow and enzyme induction in man. Br J Clin Pharmacol 3: 352P-353P
Wada O, Yano Y (1974) Adaptive responses of the liver to foreign compounds, with special reference to microsomal drug metabolizing enzymes. Rev Environm Health 4: 261–282
Barka T, Popper H (1967) Liver enlargement and drug toxicity. Medicine (Baltimore) 46: 103–117
Hunter J, Thompson RPH, Rake MO, Williams R (1971) Controlled trial on phetbarbital, a nonhypnotic barbiturate, in unconjugated hyperbilirubinemia. Br Med J 2: 497–499
Pirttiaho HI, Sotaniemi EA, Ahokas JT, Pitkänen U (1978) Liver size and indices of drug metabolism in epileptics. Br J Clin Pharmacol 6: 273–278
Pirttiaho H, Pitkänen U, Rajasalmi M, Ahonen A (1980) Comparison of three methods of measuring liver blood flow. Acta Radiol (Diagn) 21: 535–539
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pirttiaho, H.I., Sotaniemi, E.A., Pelkonen, R.O. et al. Hepatic blood flow and drug metabolism in patients on enzyme-inducing anticonvulsants. Eur J Clin Pharmacol 22, 441–445 (1982). https://doi.org/10.1007/BF00542550
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00542550